Mr. Anderson has joined AVM to build out the corporate infrastructure and the regulated clinical and commercial environment for the successful launch of AVM0703 in the treatment of relapsed/refractory lymphocytic blood cancers and refractory autoimmune disease.
Mr. Anderson has held key management and executive positions, including in the highly regulated banking industry. As CEO and President, Mr. Anderson helped lead a Seattle-based commercial bank to profitability within one year of taking the reins, which ultimately attracted a sale. He was responsible for the seamless integration of the staff, systems, and processes. He also spent nine years as CFO/Controller for a closely-held manufacturing company. Mr. Anderson has a long history of building and leading strong teams, developing internal and external productive relationships, and workly effectively in government-regulated environments. He brings strong financial skills, good communications skills, and a long, proven ability to produce desired results.